Ming-Da Wang

2.1k total citations
76 papers, 1.2k citations indexed

About

Ming-Da Wang is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, Ming-Da Wang has authored 76 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hepatology, 32 papers in Epidemiology and 20 papers in Cancer Research. Recurrent topics in Ming-Da Wang's work include Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Liver Disease Diagnosis and Treatment (27 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers). Ming-Da Wang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Liver Disease Diagnosis and Treatment (27 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers). Ming-Da Wang collaborates with scholars based in China, Hong Kong and United States. Ming-Da Wang's co-authors include Tian Yang, Feng Shen, Lei Liang, Wan Yee Lau, Mengchao Wu, Han Wu, Timothy M. Pawlik, Hao Xing, Chao Li and Ting‐Hao Chen and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ming-Da Wang

69 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming-Da Wang China 21 622 424 370 287 253 76 1.2k
Kazunori Kawaguchi Japan 20 371 0.6× 330 0.8× 93 0.3× 196 0.7× 239 0.9× 68 1.1k
Shan–Shan Zou China 16 205 0.3× 268 0.6× 333 0.9× 579 2.0× 405 1.6× 28 1.3k
Andrew Cameron United States 16 323 0.5× 150 0.4× 69 0.2× 174 0.6× 159 0.6× 36 812
Chengzhan Zhu China 14 137 0.2× 76 0.2× 163 0.4× 332 1.2× 166 0.7× 44 766
Fuchen Liu China 15 108 0.2× 127 0.3× 235 0.6× 373 1.3× 108 0.4× 51 727
Mingxuan Feng China 16 122 0.2× 126 0.3× 488 1.3× 857 3.0× 210 0.8× 48 1.3k
Ester Gonzalez‐Sanchez Spain 15 116 0.2× 132 0.3× 90 0.2× 249 0.9× 185 0.7× 25 605
Wen‐Chang Wang Taiwan 13 107 0.2× 184 0.4× 197 0.5× 332 1.2× 75 0.3× 55 759
Min Feng China 18 71 0.1× 138 0.3× 140 0.4× 251 0.9× 240 0.9× 31 803

Countries citing papers authored by Ming-Da Wang

Since Specialization
Citations

This map shows the geographic impact of Ming-Da Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Da Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Da Wang more than expected).

Fields of papers citing papers by Ming-Da Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming-Da Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Da Wang. The network helps show where Ming-Da Wang may publish in the future.

Co-authorship network of co-authors of Ming-Da Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ming-Da Wang. A scholar is included among the top collaborators of Ming-Da Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming-Da Wang. Ming-Da Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yuan, Qiming, Xianghong Zhou, Li Ma, et al.. (2024). The Association Between Solid Fuel Use and Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Sichuan, China: Cross-Sectional Study. JMIR Public Health and Surveillance. 10. e53673–e53673. 1 indexed citations
3.
Sun, Li‐Yang, Yong‐Kang Diao, Zhuping Fan, et al.. (2023). Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score. Hepatobiliary & pancreatic diseases international. 24(4). 412–422. 9 indexed citations
4.
Wang, Ming-Da, Yuan Chen, Yingjian Liang, et al.. (2023). Efficacy of ginseng-based Renshenguben oral solution for cancer-related fatigue among patients with advanced-stage hepatocellular carcinoma: A prospective multicenter cohort study. Hepatobiliary & pancreatic diseases international. 23(3). 249–256. 1 indexed citations
5.
Yao, Lan‐Qing, Chao Li, Yong‐Kang Diao, et al.. (2023). Grading severity of microscopic vascular invasion was independently associated with recurrence and survival following hepatectomy for solitary hepatocellular carcinoma. HepatoBiliary Surgery and Nutrition. 13(1). 16–28. 8 indexed citations
6.
Fan, Zhongqi, Yutao Liu, Chengcheng Li, et al.. (2023). T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis. iScience. 27(1). 108701–108701. 8 indexed citations
7.
8.
Liu, Siyu, Li‐Yang Sun, Lan‐Qing Yao, et al.. (2022). Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter Analysis. Journal of Clinical Medicine. 11(17). 5075–5075. 23 indexed citations
9.
10.
11.
12.
Xing, Hao, Lei Liang, Hong Wang, et al.. (2020). Multicenter analysis of long-term oncologic outcomes of hepatectomy for elderly patients with hepatocellular carcinoma. HPB. 22(9). 1314–1323. 15 indexed citations
13.
14.
Sun, Li‐Yang, Wentao Yan, Bing Quan, et al.. (2019). Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis. Surgery. 169(4). 911–920. 35 indexed citations
15.
Xing, Hao, Wanguang Zhang, Matteo Cescon, et al.. (2019). Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study. HPB. 22(5). 677–689. 55 indexed citations
16.
Li, Zhenli, Jun Han, Kai Liu, et al.. (2019). Association of family history with long-term prognosis in patients undergoing liver resection of HBV-related hepatocellular carcinoma. HepatoBiliary Surgery and Nutrition. 8(2). 88–100. 9 indexed citations
17.
Qin, Chenjie, Linghao Zhao, Xu Zhou, et al.. (2018). Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2. Cancer Letters. 420. 26–37. 48 indexed citations
18.
19.
Li, Zhenli, Wentao Yan, Zhang Jin, et al.. (2018). Identification of Actual 10-Year Survival After Hepatectomy of HBV-Related Hepatocellular Carcinoma: a Multicenter Study. Journal of Gastrointestinal Surgery. 23(2). 288–296. 20 indexed citations
20.
Wang, Ming-Da & Han Wu. (2017). Research progresses of primary liver cancer from 2017 annual meeting of Chinese Society of Clinical Oncology. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 16(11). 1109–1112. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazunori Kawaguchi Breakdown of academic impact, for papers by Shan–Shan Zou Breakdown of academic impact, for papers by Andrew Cameron Breakdown of academic impact, for papers by Chengzhan Zhu Breakdown of academic impact, for papers by Fuchen Liu Breakdown of academic impact, for papers by Mingxuan Feng Breakdown of academic impact, for papers by Ester Gonzalez‐Sanchez Breakdown of academic impact, for papers by Wen‐Chang Wang Breakdown of academic impact, for papers by Min Feng
Rankless by CCL
2026